Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-&beta;1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 6

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

268

HTML

1464

Figures (1-6)

242

Tables (1-1)

204

Sum=2178

Feb 14, 2006 (publication date) through Feb 1, 2025

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Rapid Communication

World J Gastroenterol. Feb 14, 2006; 12(6): 961-965
Published online Feb 14, 2006. doi: 10.3748/wjg.v12.i6.961

Full Size Figure Download Figure

Figure 5 Comparison of VEGF levels (mean and SE) before and after the antiviral therapy of CHC patients depending on treatment efficacy.

Citation: Janczewska-Kazek E, Marek B, Kajdaniuk D, Borgiel-Marek H. Effect of interferon alpha and ribavirin treatment on serum levels of transforming growth factor-β1, vascular endothelial growth factor, and basic fibroblast growth factor in patients with chronic hepatitis C. World J Gastroenterol 2006; 12(6): 961-965
URL: https://www.wjgnet.com/1007-9327/full/v12/i6/961.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i6.961